Pharmaceuticals
-
Women resist breast cancer prevention drug
Women identified as being at high risk of breast cancer are strongly resistant to taking preventative treatments, according to an analysis published today. Read more
-
Ebola trial launched
The first randomised controlled trial of a multi-drug treatment for Ebola has begun in Africa, it has been announced. Read more
-
Vitamin B12 testing in type-2 diabetes
Regular checking of the vitamin B12 levels of patients with type 2 diabetes taking metformin can help prevent irreversible nerve damage, a conference will hear today. Read more
-
Drug combination for neuroblastoma?
A new drug combination has shown “highly significant” results in laboratory tests on neuroblastoma, a European conference will hear today. Read more
-
HER2 cancers respond well to new drug
People with cancers of the oesophagus, stomach and colon have experienced positive results from a new anti-HER2 drug, a European conference is being told today. Read more
-
Obesity link to early antibiotics
Children who are given antibiotics and antacids in early life may face an increased risk of becoming obese, researchers warn today. Read more
-
ACEIs linked to increased risk of lung cancer
Some blood pressure drugs have been linked to an increased risk of lung cancer, according to a new observational study. Read more
-
Antibiotics, the ‘avoidable trigger’ for bowel disease
A high fibre diet should be followed when taking antibiotics because the drugs can predispose the gut to avoidable infections that trigger bowel disease in mice. Read more
-
New bid to change public view on antibiotics
A new campaign has been launched to try to change public understanding of antibiotics amid concern that the drugs could soon lose effectiveness. Read more
-
Hope for immunotherapy in triple negative breast cancer care
A trial of immunotherapy has shown for the first time it can extend life in patients with triple-negative breast cancer, a conference has heard. Read more
